Momenta Pharma (MNTA)
$52.48 0.00 (0.00%)
19:41 EDT MNTA Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 4.07B
PE Ratio -38.31
Volume (Avg. Vol.)
Day's Range 52.48 - 52.48
52-Week Range 20.53 - 52.50
Dividend & Yield N/A (N/A)
MNTA Stock Predictions, Articles, and Momenta Pharma News
- From InvestorPlace
- From the Web
Momenta Pharmaceuticals stock was thrust into the financial headlines and might look tempting, but don't forget that price is king.
Momenta Pharmaceuticals (MNTA) news for Wednesday includes a deal with Johnson & Johnson (JNJ) sending MNTA stock rocketing higher.
Thinking about buying Mylan stock? You may not want to just yet. It's toying with a support line that, if it snaps, could open the selling floodgates.
Teva Pharmaceutical desperately needs a new CEO - and a new strategy to boot - to stop the steady decline in TEVA stock.
Teva Pharmaceutical (TEVA) has more upside than most investors realize. Look past the Copaxone debacle, and TEVA stock is promising.
Despite Teva's (TEVA) gains on earnings and rival delays, TEVA stock is still facing impassive sentiment and broad selling pressure.
Small caps are well positioned to benefit from a reduction in tax rates. Consider these 5 stocks to buy on a tax rate reduction